Syncope, Hypotension, and Falls in the Treatment of Hypertension: Results from the Randomized Clinical Systolic Blood Pressure Intervention Trial

Journal of the American Geriatrics Society

Volumn 66, Issue 4, 2018, Pages 679-686

  Sink, Kaycee M ^a   Evans, Gregory W ^a   Shorr, Ronald I ^b,c   Bates, Jeffrey T ^d,e   Berlowitz, Dan ^b,f,g   Conroy, Molly B ^h   Felton, Deborah M ^a   Gure, Tanya ⁱ   Johnson, Karen C ^j   Kitzman, Dalane ^a   Lyles, Mary F ^a   Servilla, Karen ^k   Supiano, Mark A ^h,l   Whittle, Jeff ^m,n   Wiggers, Alan ^o   Fine, Lawrence J ^p  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g BOSTON UNIVERSITY   (United States)

^h UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

ⁱ THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^j UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^k NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

^l GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^m CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁿ MEDICAL COLLEGE OF WISCONSIN   (United States)

^o OHIO UNIVERSITY   (United States)

^p NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

more..

Author keywords

antihypertensive; falls; hypotension; older adults; syncope

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; COMORBIDITY; CONTROLLED STUDY; FAINTNESS; FALLING; FRAILTY; HUMAN; HYPERTENSION; HYPOTENSION; MAJOR CLINICAL STUDY; ORTHOSTATIC HYPOTENSION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; UNITED STATES; VERY ELDERLY; ADULT; BLOOD PRESSURE; FEMALE; MALE; MIDDLE AGED; PHYSIOLOGY; PREVENTION AND CONTROL; RISK FACTOR; TIME FACTOR;

ACCIDENTAL FALLS; ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COMORBIDITY; FEMALE; HUMANS; HYPERTENSION; HYPOTENSION; MALE; MIDDLE AGED; RISK FACTORS; SYNCOPE; TIME FACTORS;

EID: 85044595447     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.15236     Document Type: Article

References (20)

1. Yoon SS, Gu Q, Nwankwo T et al. Trends in blood pressure among adults with hypertension: United States, 2003 to 2012. Hypertension 2015;65:54–61.
2. Musini VM, Tejani AM, Bassett K et al. Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev 2009;4:CD000028.
3. Corrao G, Mazzola P, Monzio CM et al. Antihypertensive medications, loop diuretics, and risk of hip fracture in the elderly: A population-based cohort study of 81,617 Italian patients newly treated between 2005 and 2009. Drugs Aging 2015;32:927–936.
4. Tinetti ME, Han L, Lee DS et al. Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults. JAMA Intern Med 2014;174:588–595.
5. Chen L, Chen MH, Larson MG et al. Risk factors for syncope in a community-based sample (the Framingham Heart Study). Am J Cardiol 2000;85:1189–1193.
6. Shumway-Cook A, Ciol MA, Hoffman J et al. Falls in the Medicare population: Incidence, associated factors, and impact on health care. Phys Ther 2009;89:324–332.
7. Tinetti ME, Williams CS. The effect of falls and fall injuries on functioning in community-dwelling older persons. J Gerontol A Biol Sci Med Sci 1998;53A:M112–M119.
8. Tajeu GS, Delzell E, Smith W et al. Death, debility, and destitution following hip fracture. J Gerontol A Biol Sci Med Sci 2014;69A:346–353.
9. Margolis KL, Palermo L, Vittinghoff E et al. Intensive blood pressure control, falls, and fractures in patients with type 2 diabetes: The ACCORD trial. J Gen Intern Med 2014;29:1599–1606.
10. Lipsitz LA, Habtemariam D, Gagnon M et al. Reexamining the effect of antihypertensive medications on falls in old age. Hypertension 2015;66:183–189.
11. Wright JT Jr, Williamson JD, Whelton PK et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015;373:2103–2116.
12. Williamson JD, Supiano MA, Applegate WB et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged >/=75 years: A randomized clinical trial. JAMA 2016;315:2673–2682.
13. Ortiz E, James PA. Let's not SPRINT to judgment about new blood pressure goals. Ann Intern Med 2016;164:692–693.
14. Ambrosius WT, Sink KM, Foy CG et al. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials 2014;11:532–546.
15. Pajewski NM, Williamson JD, Applegate WB et al. Characterizing frailty status in the Systolic Blood Pressure Intervention Trial. J Gerontol A Biol Sci Med Sci 2016;71A:649–655.
16. Morisky DE, Ang A, Krousel-Wood M et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008;10:348–354.
17. Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication nonadherence: Response to authors. J Clin Epidemiol 2011;64:255–257.
18. Krousel-Wood M, Islam T, Webber LS et al. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care 2009;15:59–66.
19. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991;265:3255–3264.
20. Benavente OR, Coffey CS, Conwit R et al. Blood-pressure targets in patients with recent lacunar stroke: The SPS3 randomised trial. Lancet 2013;382:507–515.